Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Future of Experimental Medicine ~ Inflammation in Disease and Ageing
Novotel Manly Pacific Hotel, Manly Beach, Sydney, Australia. March 16-19, 2014---just held conference.

"Broad themes and Topics include:
Immunology | Cancer | Pathogenesis of Autoimmune and Allergic Diseases | Cardiovascular diseases | Nutrition and Inflammatory Diseases

Inflammation and Skin diseases | Inflammation and Liver Disease
Novel Therapies | Innate Mechanisms of Tissue Inflammation
Regulation of Inflammation by Cell migration | Inflammation and Ageing
Regulation of Inflammation by Endothelial Cells"

Article at:
http://femc.mtci.com.au/

Too bad Dr Mullan is busy growing RCPI, I would think he would fit into this agenda extremely well. But it does show quantum jumps in the research and interest of inflammation and it's connection with autoimmune dosorders, aging, and cancers.